whitepaper

Application note: Reliable Single Cell Cloning with Advanced Microfluidic Dispensing

Posted: 24 October 2019 | | No comments yet

Find out how to accelerate and improve selective single cell cloning with advanced microfluidic dispensing.

Ensuring that biotherapeutics are derived from a single clonal source has been stipulated by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) in order to ensure consistency and quality of production and to reduce population heterogeneity. Aligned with these requirements, the Cyto-Mine® Single Cell Analysis System has been specifically designed to safeguard monoclonality via accurate and reliable single cell dispensing.

To demonstrate the suitability of Cyto-Mine® as a tool for cloning cells, we conducted a study to examine the fidelity of Cyto-Mine’s advanced microfluidic dispensing technology.

Read the application note to learn how Cyto-Mine’s streamlined workflow offers:

  • single cell visualisation providing evidence of monoclonality to support regulatory requirements.
  • very high dispensing fidelity observed at ≥ 98.9% accuracy.











To read this Application Note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Sphere Fluidics Ltd

Send this to a friend